Pfizer, joining Lilly, enters the direct-to-consumer market with a telehealth and prescription platform
Published On Aug 27, 2024, 8:02 AM
Pfizer is entering the direct-to-consumer market with a new telehealth and prescription platform, following in the footsteps of Eli Lilly. This initiative aims to provide a convenient way for patients to access medications and health services, targeting a growing trend in telehealth and online prescription services.
Stock Forecasts
PFE
Positive
Pfizer's entry into direct-to-consumer telehealth services aligns with current healthcare trends, potentially increasing their customer base and revenue streams. This move could enhance their competitive positioning in the pharmaceutical industry.
Related News
On Drug Prices, Harris Pushes for Deeper Cuts While Trump Offers Few Specifics
Oct 8, 2024, 1:07 PM
Both have campaigned for lower prescription costs. Kamala Harris has promised to expand President Biden’s policies. Donald Trump is a wild card.
Stock market today: Dow tumbles 400 points, tech rout leads Nasdaq, S&P 500 lower as 10-year yield tops 4%
Oct 7, 2024, 4:04 PM
Investors have overhauled their views on interest rate cuts after a blowout jobs report, ahead of a week of key inflation data and the start of earnings season.
Stock market today: Dow, S&P 500, Nasdaq slide as 10-year Treasury yield, oil jump
Oct 7, 2024, 2:58 PM
Investors have overhauled their views on interest rate cuts after a blowout jobs report, ahead of a week of key inflation data and the start of earnings season.